Your browser doesn't support javascript.
loading
Expert-augmented automated machine learning optimizes hemodynamic predictors of spinal cord injury outcome.
Chou, Austin; Torres-Espin, Abel; Kyritsis, Nikos; Huie, J Russell; Khatry, Sarah; Funk, Jeremy; Hay, Jennifer; Lofgreen, Andrew; Shah, Rajiv; McCann, Chandler; Pascual, Lisa U; Amorim, Edilberto; Weinstein, Philip R; Manley, Geoffrey T; Dhall, Sanjay S; Pan, Jonathan Z; Bresnahan, Jacqueline C; Beattie, Michael S; Whetstone, William D; Ferguson, Adam R.
Afiliação
  • Chou A; Weill Institute for Neurosciences, Brain and Spinal Injury Center, University of California, San Francisco (UCSF), San Francisco, California, United States of America.
  • Torres-Espin A; Department of Neurological Surgery, University of California, San Francisco (UCSF), San Francisco, California, United States of America.
  • Kyritsis N; Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States of America.
  • Huie JR; Weill Institute for Neurosciences, Brain and Spinal Injury Center, University of California, San Francisco (UCSF), San Francisco, California, United States of America.
  • Khatry S; Department of Neurological Surgery, University of California, San Francisco (UCSF), San Francisco, California, United States of America.
  • Funk J; Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States of America.
  • Hay J; Weill Institute for Neurosciences, Brain and Spinal Injury Center, University of California, San Francisco (UCSF), San Francisco, California, United States of America.
  • Lofgreen A; Department of Neurological Surgery, University of California, San Francisco (UCSF), San Francisco, California, United States of America.
  • Shah R; Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States of America.
  • McCann C; Weill Institute for Neurosciences, Brain and Spinal Injury Center, University of California, San Francisco (UCSF), San Francisco, California, United States of America.
  • Pascual LU; Department of Neurological Surgery, University of California, San Francisco (UCSF), San Francisco, California, United States of America.
  • Amorim E; Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States of America.
  • Weinstein PR; DataRobot, Inc., Boston, Massachusetts, United States of America.
  • Manley GT; DataRobot, Inc., Boston, Massachusetts, United States of America.
  • Dhall SS; DataRobot, Inc., Boston, Massachusetts, United States of America.
  • Pan JZ; DataRobot, Inc., Boston, Massachusetts, United States of America.
  • Bresnahan JC; DataRobot, Inc., Boston, Massachusetts, United States of America.
  • Beattie MS; DataRobot, Inc., Boston, Massachusetts, United States of America.
  • Whetstone WD; Orthopedic Trauma Institute, Department of Orthopedic Surgery, University of California, San Francisco (UCSF), San Francisco, California, United States of America.
  • Ferguson AR; Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, United States of America.
PLoS One ; 17(4): e0265254, 2022.
Article em En | MEDLINE | ID: mdl-35390006
Artificial intelligence and machine learning (AI/ML) is becoming increasingly more accessible to biomedical researchers with significant potential to transform biomedicine through optimization of highly-accurate predictive models and enabling better understanding of disease biology. Automated machine learning (AutoML) in particular is positioned to democratize artificial intelligence (AI) by reducing the amount of human input and ML expertise needed. However, successful translation of AI/ML in biomedicine requires moving beyond optimizing only for prediction accuracy and towards establishing reproducible clinical and biological inferences. This is especially challenging for clinical studies on rare disorders where the smaller patient cohorts and corresponding sample size is an obstacle for reproducible modeling results. Here, we present a model-agnostic framework to reinforce AutoML using strategies and tools of explainable and reproducible AI, including novel metrics to assess model reproducibility. The framework enables clinicians to interpret AutoML-generated models for clinical and biological verifiability and consequently integrate domain expertise during model development. We applied the framework towards spinal cord injury prognostication to optimize the intraoperative hemodynamic range during injury-related surgery and additionally identified a strong detrimental relationship between intraoperative hypertension and patient outcome. Furthermore, our analysis captured how evolving clinical practices such as faster time-to-surgery and blood pressure management affect clinical model development. Altogether, we illustrate how expert-augmented AutoML improves inferential reproducibility for biomedical discovery and can ultimately build trust in AI processes towards effective clinical integration.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Traumatismos da Medula Espinal / Inteligência Artificial Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Traumatismos da Medula Espinal / Inteligência Artificial Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos